A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older with Cystic Fibrosis

Dunitz, Jordan M (PI)

Pulmonary, Allergy, Critical Care and Sleep Medicine

Project: Research project

Description

A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older with Cystic Fibrosis

Status	Finished
Effective start/end date	3/21/19 → 1/1/21

Funding

Vertex Pharmaceuticals Incorporated